How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
Description:
The purpose of this study is to explore the effectiveness of 68Ga-grazytracer PET/CT in early evaluation of neoadjuvant immunotherapy response in resectable NSCLC.
Sponsor:
Ruijin Hospital
Contacts:
Hecheng Li, MD, PHDlihecheng2000@hotmail.com
021-74370045
Government Study Link:
NCT06756217 - Click here to see study onClinicalTrials.gov
68Ga-grazytracer
Isotope(s):
Target(s):
- Granzyme B
